Fed's Powell set to speak as economists fret about a policy mistake, election risk [Yahoo! Finance Canada]
Innate Pharma S.A. - American Depositary Shares (IPHA)
Company Research
Source: Yahoo! Finance Canada
By Howard Schneider NASHVILLE, Tennessee (Reuters) - A mistake by the U.S. central bank in setting interest rates during the last phase of its inflation battle is the main risk that could undercut the economy over the next year, according to a new survey of economists released as Federal Reserve Chair Jerome Powell was set to speak on Monday. Among 32 professional forecasters surveyed recently by the National Association for Business Economics, 39% cited a "monetary policy mistake" as the "greatest downside risk to the U.S. economy over the next 12 months." By contrast, 23% regarded the outcome of the Nov. 5 U.S. presidential election as the biggest downside risk and the same number cited an intensification of the conflicts in Ukraine and the Middle East. The responses in the survey, which was released on Sunday, show the intense focus on the Fed as it eases monetary policy while hoping to both keep inflation on a steady decline back to its 2% target and avoid a significant add
Show less
Read more
Impact Snapshot
Event Time:
IPHA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPHA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPHA alerts
High impacting Innate Pharma S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IPHA
News
- Innate Pharma S.A. (NASDAQ: IPHA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.50 price target on the stock.MarketBeat
- 3 Promising Penny Stocks With Market Caps Under US$500M [Yahoo! Finance]Yahoo! Finance
- Innate Pharma Announces First Patient Dosed in Phase 1 Study of Its Nectin-4 Targeting Antibody Drug Conjugate IPH4502 in Selected Advanced Solid TumorsBusiness Wire
- Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York [Yahoo! Finance]Yahoo! Finance
- Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New YorkBusiness Wire